|
African Doctors Receive Subspecialty Training Through
Newly Created Corporation
Dr. Lawrason’s Support Allows Ugandan Doctors to Train
at Waterbury Hospital
WATERBURY
–Two physicians from the African country of Uganda will
receive subspecialty training at Waterbury Hospital and
Yale New Haven Hospital, thanks to the support of a
tax-exempt corporation established by Jock Lawrason, MD,
Chairman of the Department of Medicine at Waterbury
Hospital and Chief Medical Officer of the Alliance
Medical Group.
The Yale-Mulago Medical
Fellowship Corporation, created over a year and a half
ago by Dr. Lawrason and his family, has teamed up with
Mulago Hospital in Kampala, Uganda, in an effort to
provide advanced training for physicians and other
clinicians bringing badly needed care to patients across
East Africa.
Two Ugandan physicians --
Christopher Opio, MD,
and Rejani Lalitha,
MD -- began their training in October. While
the program is associated directly with Yale University,
much of the training that the two physicians will
receive will take place at Waterbury Hospital.
Majid Sadigh, MD,
a Clinician Educator at Waterbury Hospital who is also
Director of the Yale Global Health Office, will oversee
their training at Waterbury Hospital.
Dr. Sadigh said the newly
created corporation will give Uanda and other East
African countries access to some of the very best
medical care to be found in the world today. Funding
from the corporation is being used to cover living
expenses for the physicians while they are training.
“We’re very happy to be
able to come here and bring this kind of specialized
medicine back to our country,” Dr. Opio said, who is
focusing his training on internal medicine and
gastroenterology Dr. Lalitha is focusing her training on
emergency medicine and intensive care medicine.
Dr. Lawrason said the
corporation has pledged to continue funding the program
for the foreseeable future. For more information, please
contact Dr. Sadigh at (203) 573-6246.
Please see attached photo, from left:
Rejani Lalitha, MD;
Majid Sadigh, MD; Jock Lawrason, MD; and
Christopher Opio, MD.
|